Literature DB >> 25245215

The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.

Rami I Aqeilan1, Muhannad Abu-Remaileh, Mohammad Abu-Odeh.   

Abstract

The fragile WWOX gene, encompassing the chromosomal fragile site FRA16D, is frequently altered in human cancers. While vulnerable to DNA damage itself, recent evidence has shown that the WWOX protein is essential for proper DNA damage response (DDR). Furthermore, the gene product, WWOX, has been associated with multiple protein networks, highlighting its critical functions in normal cell homeostasis. Targeted deletion of Wwox in murine models suggests its in vivo requirement for proper growth, metabolism, and survival. Recent molecular and biochemical analyses of WWOX functions highlighted its role in modulating aerobic glycolysis and genomic stability. Cumulatively, we propose that the gene product of FRA16D, WWOX, is a functionally essential protein that is required for cell homeostasis and that its deletion has important consequences that contribute to the neoplastic process. This review discusses the essential role of WWOX in tumor suppression and genomic stability and how its alteration contributes to cancer transformation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25245215     DOI: 10.1007/s00018-014-1724-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  106 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

3.  A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas.

Authors:  Ge Gao; Jan L Kasperbauer; Nicole M Tombers; Vivian Wang; Kevin Mayer; David I Smith
Journal:  Genes Chromosomes Cancer       Date:  2014-01-31       Impact factor: 5.006

4.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Authors:  Sai Yendamuri; Tamotsu Kuroki; Francesco Trapasso; Adam C Henry; Kristoffel R Dumon; Kay Huebner; Noel N Williams; Larry R Kaiser; Carlo M Croce
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

Review 6.  Instability at chromosomal fragile sites.

Authors:  T W Glover
Journal:  Recent Results Cancer Res       Date:  1998

7.  Scaffolding protein SPIDR/KIAA0146 connects the Bloom syndrome helicase with homologous recombination repair.

Authors:  Li Wan; Jinhua Han; Ting Liu; Shunli Dong; Feng Xie; Hongxia Chen; Jun Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

8.  RORA, a large common fragile site gene, is involved in cellular stress response.

Authors:  Y Zhu; S McAvoy; R Kuhn; D I Smith
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

Review 9.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.

Authors:  Z Salah; T Bar-mag; Y Kohn; F Pichiorri; T Palumbo; G Melino; R I Aqeilan
Journal:  Cell Death Dis       Date:  2013-01-31       Impact factor: 8.469

View more
  18 in total

1.  Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma.

Authors:  Wei Yang; Xiao-Ming Wang; Hong-Yan Yuan; Zhi-Hui Liu; Shuang Gao; Liang Peng
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

Review 2.  Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells.

Authors:  Muhannad Abu-Remaileh; Emma Joy-Dodson; Ora Schueler-Furman; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

3.  WWOX guards genome stability by activating ATM.

Authors:  Idit Hazan; Mohammad Abu-Odeh; Thomas G Hofmann; Rami I Aqeilan
Journal:  Mol Cell Oncol       Date:  2015-02-23

4.  Current questions and controversies in chromosome fragile site research: does WWOX, the gene product of common fragile site FRA16D, have a passive or active role in cancer?

Authors:  I Hazan; R I Aqeilan
Journal:  Cell Death Discov       Date:  2015-10-19

Review 5.  Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response.

Authors:  Idit Hazan; Thomas G Hofmann; Rami I Aqeilan
Journal:  PLoS Genet       Date:  2016-12-15       Impact factor: 5.917

6.  Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.

Authors:  Wanyong Chen; Chenhao Zhou; Wentao Zhang; Manar Atyah; Yirui Yin; Lei Guo; Weiguo Tang; Qiongzhu Dong; Qinghai Ye; Ning Ren
Journal:  J Cancer       Date:  2018-03-14       Impact factor: 4.207

7.  Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function.

Authors:  Sara Del Mare; Rami I Aqeilan
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

8.  WWOX modulates the ATR-mediated DNA damage checkpoint response.

Authors:  Mohammad Abu-Odeh; Nyla A Hereema; Rami I Aqeilan
Journal:  Oncotarget       Date:  2016-01-26

9.  Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk.

Authors:  Hsin-Lin Cheng; Yu-Fan Liu; Chun-Wen Su; Shih-Chi Su; Mu-Kuan Chen; Shun-Fa Yang; Chiao-Wen Lin
Journal:  Oncotarget       Date:  2016-10-25

10.  WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.

Authors:  Muhannad Abu-Remaileh; Abed Khalaileh; Eli Pikarsky; Rami I Aqeilan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.